Continued Dexamethasone at Discharge Not Tied to Better COVID-19 Outcomes

No association seen with reduced 14-day all-cause readmission or mortality for individuals continuing dexamethasone at discharge.

Related Keywords

Cheng Wei Huang , Kaiser Permanente Los Angeles Medical Center , Healthday News , Wei Huang ,